E-ISSN 2636-834X
 
2024, Vol: 14, Issue: 1
14 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

COPYRIGHT FORM
_Title_Page_Obligatory_(v2r)_

Case Report 


Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report

Orkun Aydin, Pinar Unal-Aydin.


Abstract
Hyperprolactinemia is a severe problem which involves galactorrhea, amenorrhea, sexual dysfunction, and lowered bone mineral density. It can be a long-lasting problem belongs to the atypical antipsychotics that impairs treatment adherence and quality of life in patients with schizophrenia. The paliperidone palmitate may cause hyperprolactinemia and there are different approaches in management of this adverse event. Adding oral aripiprazole was shown to be useful in the treatment of hyperprolactinemia due to paliperidone palmitate. Now the new drug long-acting Injectable (LAI) aripiprazole may become a possible new agent in treatment of schizophrenia patients with paliperidone palmitate induced hyperprolactinemia.

Key words: aripiprazole LAI, paliperidone palmitate, hyperprolactinemia, amenorrhea, galactorrhea


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Orkun Aydin
Articles by Pinar Unal-Aydin
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Orkun Aydin, Pinar Unal-Aydin. Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report. PBS. 2017; 7(4): 234-6. doi:10.5455/jmood.20171002125925

Web Style

Orkun Aydin, Pinar Unal-Aydin. Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report. https://www.pbsciences.org/?mno=279723 [Access: April 11, 2024]. doi:10.5455/jmood.20171002125925

AMA (American Medical Association) Style

Orkun Aydin, Pinar Unal-Aydin. Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report. PBS. 2017; 7(4): 234-6. doi:10.5455/jmood.20171002125925


Vancouver/ICMJE Style

Orkun Aydin, Pinar Unal-Aydin. Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report. PBS. (2017), [cited April 11, 2024]; 7(4): 234-6. doi:10.5455/jmood.20171002125925


Harvard Style

Orkun Aydin, Pinar Unal-Aydin (2017) Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report. PBS, 7 (4), 234-6. doi:10.5455/jmood.20171002125925


Turabian Style

Orkun Aydin, Pinar Unal-Aydin. 2017. Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report. Psychiatry and Behavioral Sciences, 7 (4), 234-6. doi:10.5455/jmood.20171002125925


Chicago Style

Orkun Aydin, Pinar Unal-Aydin. "Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report." Psychiatry and Behavioral Sciences 7 (2017), 234-6. doi:10.5455/jmood.20171002125925


MLA (The Modern Language Association) Style

Orkun Aydin, Pinar Unal-Aydin. "Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report." Psychiatry and Behavioral Sciences 7.4 (2017), 234-6. Print. doi:10.5455/jmood.20171002125925


APA (American Psychological Association) Style

Orkun Aydin, Pinar Unal-Aydin (2017) Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report. Psychiatry and Behavioral Sciences, 7 (4), 234-6. doi:10.5455/jmood.20171002125925


Author LoginReviewer Login

About Psychiatry and Behavioral Sciences

Psychiatry and Behavioral Sciences is a scientific journal currently published by Turkish Association for Psychopharmacology.  It has been published as ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Editor in Chief

Prof. Dr. Mesut ÇETİN
Address: Bagdat Cad. Birgen Is Merkezi 226/7 Kadikoy - Istanbul - TURKEY 34728Phone:+90 (532) 272 32 52E-mail:psikofarmakoloji@gmail.com